Anders Jorgensen
Overview
Explore the profile of Anders Jorgensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
409
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Deng Z, Ousdal O, Oltedal L, Angulo B, Baradits M, Spitzberg A, et al.
Res Sq
. 2023 Jul;
PMID: 37398308
Neurostimulation is a mainstream treatment option for major depression. Neuromodulation techniques apply repetitive magnetic or electrical stimulation to some neural target but significantly differ in their invasiveness, spatial selectivity, mechanism...
12.
Jorgensen A, Brandslund I, Ellervik C, Henriksen T, Weimann A, Andersen P, et al.
Aging Cell
. 2023 May;
22(6):e13839.
PMID: 37190886
Modifications of nucleic acids (DNA and RNA) from oxidative stress is a potential driver of aging per se and of mortality in age-associated medical disorders such as type 2 diabetes...
13.
Staerk M, Jorgensen A, Hadad Z
Ugeskr Laeger
. 2023 Apr;
185(16).
PMID: 37114571
Pseudoaneurysms and thrombosis in the jugular vein are very rare. This case report presents a case of a 57-year-old female with a thrombosis in the internal jugular vein and a...
14.
Kohler-Forsberg K, Dam V, Ozenne B, Sankar A, Beliveau V, Landman E, et al.
JAMA Psychiatry
. 2023 Feb;
80(4):296-304.
PMID: 36753296
Importance: The cerebral serotonin 4 (5-HT4) receptor is a promising novel target for treatment of major depressive disorder (MDD), and pharmacological stimulation of the 5-HT4 receptor has been associated with...
15.
Jorgensen T, Osler M, Jorgensen M, Jorgensen A
Lancet Psychiatry
. 2022 Nov;
10(1):12-20.
PMID: 36450298
Background: A key clinical problem in psychiatry is predicting the diagnostic future of patients presenting with psychopathology for the first time. The objective of this study was to establish a...
16.
Jorgensen A, Baago I, Rygner Z, Jorgensen M, Andersen P, Kessing L, et al.
JAMA Psychiatry
. 2022 Aug;
79(9):920-931.
PMID: 35921094
Importance: Nucleic acid damage from oxidative stress (NA-OXS) may be a molecular mechanism driving the severely increased morbidity and mortality from somatic causes in adults with psychiatric disorders. Objective: To...
17.
Kohler-Forsberg K, Ozenne B, Larsen S, Poulsen A, Landman E, Dam V, et al.
Transl Psychiatry
. 2022 Jul;
12(1):273.
PMID: 35821015
Concurrent anxiety is frequent in major depressive disorder and a shared pathophysiological mechanism between anxiety and other depressive symptoms is plausible. The serotonin 4 receptor (5-HTR) has been implicated in...
18.
Jorgensen A, Kohler-Forsberg K, Henriksen T, Weimann A, Brandslund I, Ellervik C, et al.
Transl Psychiatry
. 2022 May;
12(1):204.
PMID: 35577781
Previous studies have indicated that antidepressants that inhibit the serotonin transporter reduces oxidative stress. DNA and RNA damage from oxidation is involved in aging and a range of age-related pathophysiological...
19.
Johannsen C, Petersen T, Nielsen J, Jorgensen A, Jimenez-Solem E, Fink-Jensen A
Ther Adv Psychopharmacol
. 2022 Mar;
12:20451253211072341.
PMID: 35273789
Introduction: The antipsychotic drug clozapine remains underutilized partly because of the risk of life-threatening adverse effects, such as neutropenia. Therefore, an extensive hematological monitoring program was set up to detect...
20.
Osler M, Rozing M, Jorgensen M, Jorgensen A
World J Biol Psychiatry
. 2021 Oct;
23(4):318-326.
PMID: 34668447
Objective: To examine whether electroconvulsive therapy (ECT) is associated with risk of mortality and acute somatic events in patients with or without somatic comorbidity. Methods: A total of 174,495 patients...